Intragen log record 40:CFR-01.Dr. Leonard Kendall, - Ingen Bio - Senior Director of Applied Biotechnology.
> I have begun longitudinal chemotherapy research on a new experimental recombinant protein: Intragen.
40_CFR_01.02
top of page
InGenBio
Corporation
®
MAKING YOUR FUTURE BETTER. TODAY.
Search
Recent Posts
See All> Cytotoxicity and its effect on lymphocytes is of utmost importance. I must find a way to balance the protein's effects. If I am...
bottom of page
Comments